<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(5)</volume><submitter>Sala M</submitter><pubmed_abstract>&lt;h4>Background &amp; aims&lt;/h4>The epidemiological landscape of hepatocellular carcinoma (HCC) in Europe is evolving. This study aims to provide an updated description of the current epidemiology of liver cancer in Spain.&lt;h4>Methods&lt;/h4>This multicenter prospective study collected demographic and clinical data on primary liver cancer between October 2022 and January 2023. We conducted descriptive and comparative analyses with data collected in 2008 and 2014.&lt;h4>Results&lt;/h4>Of the 767 cases of primary liver cancer collected from 52 centers, 91% were diagnosed as HCC. The majority of patients were male (83.3%), average age 68 years, 80.7% had cirrhosis. The primary causes were alcohol (29.9% alone, 55% combined with other etiologies), liver disease related to metabolic syndrome (LDrMS, 23%) and h</pubmed_abstract><journal>JHEP reports : innovation in hepatology</journal><pagination>101336</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12005282</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evolving epidemiology of HCC in Spain.</pubmed_title><pmcid>PMC12005282</pmcid><pubmed_authors>Cachero A</pubmed_authors><pubmed_authors>Romero-Gutierrez M</pubmed_authors><pubmed_authors>Guerrero A</pubmed_authors><pubmed_authors>Molina E</pubmed_authors><pubmed_authors>Hernaez-Alsina T</pubmed_authors><pubmed_authors>Rodriguez-Gonzalez MM</pubmed_authors><pubmed_authors>Varela M</pubmed_authors><pubmed_authors>Castro RQ</pubmed_authors><pubmed_authors>Vergara M</pubmed_authors><pubmed_authors>Giraldez A</pubmed_authors><pubmed_authors>Delgado M</pubmed_authors><pubmed_authors>Vallejo-Senra N</pubmed_authors><pubmed_authors>Rodriguez-Lope C</pubmed_authors><pubmed_authors>Olmo JF</pubmed_authors><pubmed_authors>Guerrero M</pubmed_authors><pubmed_authors>Serra HA</pubmed_authors><pubmed_authors>Lue A</pubmed_authors><pubmed_authors>Pacheco Del Rio G</pubmed_authors><pubmed_authors>Coll S</pubmed_authors><pubmed_authors>Delgado C</pubmed_authors><pubmed_authors>Montoliu S</pubmed_authors><pubmed_authors>Fernandez-Marcos C</pubmed_authors><pubmed_authors>Serra I</pubmed_authors><pubmed_authors>Ferrer MT</pubmed_authors><pubmed_authors>Llamoza-Torres CJ</pubmed_authors><pubmed_authors>Fernandez-Bermejo M</pubmed_authors><pubmed_authors>Cortes-Garcia L</pubmed_authors><pubmed_authors>Sanchez AG</pubmed_authors><pubmed_authors>Gacho PC</pubmed_authors><pubmed_authors>Reig M</pubmed_authors><pubmed_authors>Ramos IC</pubmed_authors><pubmed_authors>Campos M</pubmed_authors><pubmed_authors>Valer Lopez-Fando MP</pubmed_authors><pubmed_authors>Pascual S</pubmed_authors><pubmed_authors>Bustamante J</pubmed_authors><pubmed_authors>Bermudez-Ramos M</pubmed_authors><pubmed_authors>Rodriguez M</pubmed_authors><pubmed_authors>Cuyas B</pubmed_authors><pubmed_authors>Roget M</pubmed_authors><pubmed_authors>Diaz-Gonzalez A</pubmed_authors><pubmed_authors>Macias-Rodriguez MA</pubmed_authors><pubmed_authors>Matilla AM</pubmed_authors><pubmed_authors>Fernandez-Lopez AM</pubmed_authors><pubmed_authors>Penas I</pubmed_authors><pubmed_authors>Lledo JL</pubmed_authors><pubmed_authors>Hernandez-Guerra M</pubmed_authors><pubmed_authors>Segarra JX</pubmed_authors><pubmed_authors>Barrio ML</pubmed_authors><pubmed_authors>Gomez-Rubio M</pubmed_authors><pubmed_authors>Chiminazzo V</pubmed_authors><pubmed_authors>Morillas MJ</pubmed_authors><pubmed_authors>Gutierrez-Garcia ML</pubmed_authors><pubmed_authors>Rifa R</pubmed_authors><pubmed_authors>Montero JL</pubmed_authors><pubmed_authors>Aracil C</pubmed_authors><pubmed_authors>Rota Roca MR</pubmed_authors><pubmed_authors>Urquijo Ponce JJ</pubmed_authors><pubmed_authors>Inarrairaegui M</pubmed_authors><pubmed_authors>Diaz-Bethencourt D</pubmed_authors><pubmed_authors>Olmedo SR</pubmed_authors><pubmed_authors>Unceta PR</pubmed_authors><pubmed_authors>Gonzalez-Santiago JM</pubmed_authors><pubmed_authors>Guiberteau A</pubmed_authors><pubmed_authors>Sogbe M</pubmed_authors><pubmed_authors>Clos A</pubmed_authors><pubmed_authors>Vazquez-Rodriguez S</pubmed_authors><pubmed_authors>Minguez B</pubmed_authors><pubmed_authors>Perello C</pubmed_authors><pubmed_authors>Lazaro M</pubmed_authors><pubmed_authors>Sala M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evolving epidemiology of HCC in Spain.</name><description>&lt;h4>Background &amp; aims&lt;/h4>The epidemiological landscape of hepatocellular carcinoma (HCC) in Europe is evolving. This study aims to provide an updated description of the current epidemiology of liver cancer in Spain.&lt;h4>Methods&lt;/h4>This multicenter prospective study collected demographic and clinical data on primary liver cancer between October 2022 and January 2023. We conducted descriptive and comparative analyses with data collected in 2008 and 2014.&lt;h4>Results&lt;/h4>Of the 767 cases of primary liver cancer collected from 52 centers, 91% were diagnosed as HCC. The majority of patients were male (83.3%), average age 68 years, 80.7% had cirrhosis. The primary causes were alcohol (29.9% alone, 55% combined with other etiologies), liver disease related to metabolic syndrome (LDrMS, 23%) and h</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2025-07-08T03:11:13.97Z</modification><creation>2025-07-08T03:11:13.97Z</creation></dates><accession>S-EPMC12005282</accession><cross_references><pubmed>40248605</pubmed><doi>10.1016/j.jhepr.2025.101336</doi></cross_references></HashMap>